{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:08:09Z","timestamp":1791439689891,"version":"4.3.3"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006498","name":"Clemson University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajo.2025.02.017","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T14:12:27Z","timestamp":1740060747000},"page":"176-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-0821","authenticated-orcid":false,"given":"GEORGE","family":"MAGRATH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSEPH","family":"LUVISI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL","family":"RUSSAKOFF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JONATHAN","family":"OAKLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMIL ANTHONY","family":"SAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEFFREY","family":"BLICE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ASHWATH","family":"JAYAGOPAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SALLY","family":"TUCKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEX","family":"LOAYZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GEORGE HAMILTON","family":"BAKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIHAD S.","family":"OBEID","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2025.02.017_bib0001","first-page":"28","article-title":"Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies","volume":"7","author":"Miller","year":"2018","journal-title":"Asia Pac J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.017_bib0002","first-page":"e52676","article-title":"Diabetic macular edema management: a review of anti-vascular endothelial growth factor (VEGF) therapies","volume":"16","author":"Cheema","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.017_bib0003","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.017_bib0004","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.survophthal.2022.01.009","article-title":"Prevalence of diabetic macular edema based on optical coherence tomography in people with diabetes: a systematic review and meta-analysis","volume":"67","author":"Im","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"Feb","key":"10.1016\/j.ajo.2025.02.017_bib0005","article-title":"The type 2 diabetes \u201cmodern preventable pandemic\u201d and replicable lessons from the COVID-19 crisis","volume":"25","author":"Singer","year":"2022","journal-title":"Prev Med Rep"},{"issue":"6","key":"10.1016\/j.ajo.2025.02.017_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/2042018813512360","article-title":"Anti-vascular endothelial growth factor therapy for diabetic macular edema","volume":"4","author":"Boyer","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"Sep","key":"10.1016\/j.ajo.2025.02.017_bib0007","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","article-title":"M\u00fcller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ajo.2025.02.017_bib0008","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ajo.2025.02.017_bib0009","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/APO.0000000000000583","article-title":"Application of artificial intelligence in precision medicine for diabetic macular edema","volume":"12","author":"Li","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.017_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oret.2022.10.008","article-title":"Intravitreal steroids compared with anti-VEGF treatment for diabetic macular edema","volume":"7","author":"Patil","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"21","key":"10.1016\/j.ajo.2025.02.017_bib0011","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.3390\/jcm11216416","article-title":"Response to initial anti-vascular endothelial growth factor for diabetic macular edema is significantly correlated with response to third consecutive monthly injection","volume":"29","author":"Maeda","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.02.017_bib0012","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ajo.2011.03.008","article-title":"Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography","volume":"152","author":"Manjunath","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.02.017_bib0013","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1167\/iovs.18-25325","article-title":"Deep learning for prediction of AMD progression: a pilot study","volume":"60","author":"Russakoff","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.02.017_bib0014","series-title":"International Conference on Learning Representations","first-page":"1409","article-title":"Very deep convolutional networks for large-scale image recognition","author":"Simonyan","year":"2014"},{"key":"10.1016\/j.ajo.2025.02.017_bib0015","series-title":"International Joint Conference on Biometrics","first-page":"762","article-title":"On fine-tuning convolutional neural networks for smartphone based ocular recognition","author":"Rattani","year":"2017"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.017_bib0016","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/aos.14514","article-title":"Prediction of response to anti-vascular endothelial growth factor treatment in diabetic macular oedema using an optical coherence tomography-based machine learning method","volume":"99","author":"Cao","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.017_bib0017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/atm-20-1431","article-title":"Automatic prediction of treatment outcomes in patients with diabetic macular edema using ensemble machine learning","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"issue":"8","key":"10.1016\/j.ajo.2025.02.017_bib0018","first-page":"241","article-title":"A pilot study of machine learning models for prediction of treatment response in patients with diabetic macular edema in a phase II clinical trial","volume":"64","author":"Wen","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2025.02.017_bib0019","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1167\/iovs.12-10895","article-title":"Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema","volume":"53","author":"Comyn","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.02.017_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40942-023-00453-0","article-title":"Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice","volume":"9","author":"Gurung","year":"2023","journal-title":"Int J Retina Vitreous"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.02.017_bib0021","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.4103\/IJO.IJO_893_23","article-title":"Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema","volume":"72","author":"Rana","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2025.02.017_bib0022","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3390\/ijms23147585","article-title":"The role of intravitreal corticosteroids in the treatment of DME: predictive OCT biomarkers","volume":"23","author":"Munk","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942500073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942500073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:45:38Z","timestamp":1777567538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942500073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":22,"alternative-id":["S000293942500073X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}